SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 199.20+0.1%Nov 21 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Hippieslayer who wrote (11354)11/18/1997 6:57:00 AM
From: Henry Niman  Read Replies (1) of 32384
 
FUGAZI, I have not seen the three articles in popular press, but I think that the original information is accurate. Neither I nor LGND has much control on when or if articles are published. Other news may have pushed the publication dates back, or the SEC delay may have also affected the publications. As far as I know, they are still slated for publication.
Speaking of publications, Jesse Eisinger ( thestreet.com )has a detailed report on Rheumatoid Arthritis treatments by IMNX and CNTO (with ensuing battles among various analysts). The article closes by saying that the share of the $1.5 Billion market may be overestimated for both companies, due to advances in safe oral treatments. Of course LGND has several oral programs that could impact the condition.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext